Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Scope of the Report:
This report focuses on the Oncolytic Virus Therapy in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Market Segment by Countries, covering
United States
United Kingdom
Canada
Germany
France
Italy
Spain
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
There are 19 Chapters to deeply display the North America and Europe Oncolytic Virus Therapy market.
Chapter 1, to describe Oncolytic Virus Therapy Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Oncolytic Virus Therapy, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Oncolytic Virus Therapy, for each country, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;
Chapter 14, Oncolytic Virus Therapy market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers, etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.
Frequently Asked Questions
These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in [Keyword] business includes.
[Company list]
As per [Keyword] market analysis, North America is forecasted to occupied major share in the [Keyword] market.
The statistical data of the dominant industry player of [Keyword] market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the [Keyword] market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.
The report come up with a segment of the [Keyword] market based on Type, Region, and Application, Also offer a determined view on the [Keyword] market.
The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.
The sample report for [Keyword] market can be received after the apply from the website.
Table Of Content
Table of Contents
1 Market Overview
1.1 Oncolytic Virus Therapy Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 Melanoma
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Oncolytic Virus Therapy Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Amgen Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Oncolytics Biotech
2.2.1 Business Overview
2.2.2 Oncolytic Virus Therapy Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Viralytics
2.3.1 Business Overview
2.3.2 Oncolytic Virus Therapy Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Viralytics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Transgene SA
2.4.1 Business Overview
2.4.2 Oncolytic Virus Therapy Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Transgene SA Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Oncolys BioPharma
2.5.1 Business Overview
2.5.2 Oncolytic Virus Therapy Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Targovax
2.6.1 Business Overview
2.6.2 Oncolytic Virus Therapy Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Targovax Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 PsiOxus Therapeutics
2.7.1 Business Overview
2.7.2 Oncolytic Virus Therapy Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 SillaJen Biotherapeutics
2.8.1 Business Overview
2.8.2 Oncolytic Virus Therapy Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sorrento Therapeutics
2.9.1 Business Overview
2.9.2 Oncolytic Virus Therapy Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Lokon Pharma
2.10.1 Business Overview
2.10.2 Oncolytic Virus Therapy Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Lokon Pharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Genelux Corporation
2.11.1 Business Overview
2.11.2 Oncolytic Virus Therapy Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Genelux Corporation Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Vyriad
2.12.1 Business Overview
2.12.2 Oncolytic Virus Therapy Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Vyriad Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 TILT Biotherapeutics
2.13.1 Business Overview
2.13.2 Oncolytic Virus Therapy Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Cold Genesys
2.14.1 Business Overview
2.14.2 Oncolytic Virus Therapy Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Cold Genesys Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Oncolytic Virus Therapy Market Competition, by Manufacturer
3.1 North America and Europe Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Oncolytic Virus Therapy Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Oncolytic Virus Therapy Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Oncolytic Virus Therapy Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Oncolytic Virus Therapy Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America and Europe Oncolytic Virus Therapy Market Analysis by Countries/Regions
4.1 North America and Europe Oncolytic Virus Therapy Sales Market Share by Countries/Regions
4.2 North America and Europe Oncolytic Virus Therapy Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Oncolytic Virus Therapy Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Oncolytic Virus Therapy Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Oncolytic Virus Therapy Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Oncolytic Virus Therapy by Type
5.1 North America and Europe Oncolytic Virus Therapy Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Oncolytic Virus Therapy Revenue and Market Share by Type (2013-2018)
6 North America and Europe Market Segmentation Oncolytic Virus Therapy by Application
6.1 North America and Europe Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
6.2 Melanoma Sales Growth (2013-2018)
6.3 Prostate Cancer Sales Growth (2013-2018)
6.4 Breast Cancer Sales Growth (2013-2018)
6.5 Ovarian Cancer Sales Growth (2013-2018)
6.6 Others Sales Growth (2013-2018)
7 United States Oncolytic Virus Therapy Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
7.2.1 United States Oncolytic Virus Therapy Sales by Type (2013-2018)
7.2.2 United States Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
7.3 United States Oncolytic Virus Therapy Sales and Market Share by Application (2013-2018)
7.3.1 United States Oncolytic Virus Therapy Sales by Application (2013-2018)
7.3.2 United States Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
7.4 United States Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Oncolytic Virus Therapy Export and Import (2013-2018)
8 United Kingdom Oncolytic Virus Therapy Sales, Revenue, by Type, Application and Manufacturers
8.1 United Kingdom Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Oncolytic Virus Therapy Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Oncolytic Virus Therapy Sales by Type (2013-2018)
8.2.2 United Kingdom Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
8.3 United Kingdom Oncolytic Virus Therapy Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Oncolytic Virus Therapy Sales by Application (2013-2018)
8.3.2 United Kingdom Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
8.4 United Kingdom Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Oncolytic Virus Therapy Export and Import (2013-2018)
9 Canada Oncolytic Virus Therapy Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
9.2.1 Canada Oncolytic Virus Therapy Sales by Type (2013-2018)
9.2.2 Canada Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
9.3 Canada "&Sheet1!$B$1&" Sales and Market Share by Application (2013-2018)"
9.3.1 Canada Oncolytic Virus Therapy Sales by Application (2013-2018)
9.3.2 Canada Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
9.4 Canada Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Oncolytic Virus Therapy Export and Import (2013-2018)
10 Germany Oncolytic Virus Therapy Sales, Revenue, by Type, Application and Manufacturers
10.1 Germany Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
10.2.1 Germany Oncolytic Virus Therapy Sales by Type (2013-2018)
10.2.2 Germany Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
10.3 Germany Oncolytic Virus Therapy Sales and Market Share by Application (2013-2018)
10.3.1 Germany Oncolytic Virus Therapy Sales by Application (2013-2018)
10.3.2 Germany Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
10.4 Germany Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Oncolytic Virus Therapy Export and Import (2013-2018)
11 France Oncolytic Virus Therapy Sales, Revenue, by Type, Application and Manufacturers
11.1 France Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
11.2 France Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
11.2.1 France Oncolytic Virus Therapy Sales by Type (2013-2018)
11.2.2 France Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
11.3 France "&Sheet1!$B$1&" Sales by Application (2013-2018)"
11.3.1 France Oncolytic Virus Therapy Sales by Application (2013-2018)
11.3.2 France Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
11.4 France Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Oncolytic Virus Therapy Revenue and Market Share by Manufacturer
11.5 France Oncolytic Virus Therapy Export and Import (2013-2018)
12 Italy Oncolytic Virus Therapy Sales, Revenue, by Type, Application and Manufacturers
12.1 Italy Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
12.2.1 Italy Oncolytic Virus Therapy Sales by Type (2013-2018)
12.2.2 Italy Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
12.3 Italy Oncolytic Virus Therapy Sales and Market Share by Application (2013-2018)
12.3.1 Italy Oncolytic Virus Therapy Sales by Application (2013-2018)
12.3.2 Italy Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
12.4 Italy Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Oncolytic Virus Therapy Export and Import (2013-2018)
13 Spain Oncolytic Virus Therapy Sales, Revenue, by Type, Application and Manufacturers
13.1 Spain Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
13.2.1 Spain Oncolytic Virus Therapy Sales by Type (2013-2018)
13.2.2 Spain Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
13.3 Spain Oncolytic Virus Therapy Sales by Application (2013-2018)
13.3.1 Spain Oncolytic Virus Therapy Sales by Application (2013-2018)
13.3.2 Spain Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
13.4 Spain Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Oncolytic Virus Therapy Export and Import (2013-2018)
14 Oncolytic Virus Therapy Market Forecast (2018-2023)
14.1 North America and Europe Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2018-2023)
14.2 Oncolytic Virus Therapy Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Oncolytic Virus Therapy Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Oncolytic Virus Therapy Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Oncolytic Virus Therapy Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Oncolytic Virus Therapy Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Oncolytic Virus Therapy Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Oncolytic Virus Therapy Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Oncolytic Virus Therapy Sales and Growth Rate Forecast (2018-2023)
14.3 Oncolytic Virus Therapy Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Oncolytic Virus Therapy Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Oncolytic Virus Therapy Market Share Forecast by Type (2018-2023)
14.4 Oncolytic Virus Therapy Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Oncolytic Virus Therapy Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Oncolytic Virus Therapy Market Share Forecast by Application (2018-2023)
15 Oncolytic Virus Therapy Manufacturing Cost Analysis
15.1 Oncolytic Virus Therapy Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Oncolytic Virus Therapy
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Oncolytic Virus Therapy Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Oncolytic Virus Therapy Major Manufacturers in 2017
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Data Source
Inquiry For Buying
North America and Europe Oncolytic Virus Therapy
Please fill out the form. We will contact you within 24 hours:
All fields required...
Request Sample
North America and Europe Oncolytic Virus Therapy
Please fill out the form. We will contact you within 24 hours:
All fields required...
